Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T7RY
|
||||
Former ID |
DNC008398
|
||||
Drug Name |
6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529221] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H11Cl2N
|
||||
Canonical SMILES |
C1CNCCC2=C1C=CC(=C2Cl)Cl
|
||||
InChI |
1S/C10H11Cl2N/c11-9-2-1-7-3-5-13-6-4-8(7)10(9)12/h1-2,13H,3-6H2
|
||||
InChIKey |
WMCWIMZEYWNBOQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [529221] | |
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [529221] | ||
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [529221] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.